Teva to buy Allergan generic drug business for $40.5 billion: Reuters

Teva Pharmaceutical Industries (TEVA.TA) has agreed to buy Allergan Plc's (AGN.N) generic drugs business for $40.5 billion in a deal that will turn Teva into one of the top 10 pharmaceutical companies, Reuters News reported.

DealsNorth AmericaUSBriefs